Trial intelligence / Profile preview

Immunogenicity and Safety of AdimFlu-S 2010-2011 Influenza Vaccine

NCT01356316Phase 4Completed

Sponsor
Adimmune
Start
Aug 2010
Primary completion
Aug 2010
Modality
Vaccines & Immunotherapeutics
01

Overview

A Phase 4 trial of influenza virus vaccine, split virion in influenza, sponsored by Adimmune. Started Aug 2010; status: completed.

02

Drugs

influenza virus vaccine, split virion
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01356316.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01356316.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call